legal-news

1:24-cv-01004 Otsuka Pharmaceutical Co., Ltd. et al v. Apotex Inc. et al

updateUpdated 2 days ago
24-cv-01004 Filed
Active Active litigation Sign in to follow this case
Share mail
Advertisement
description

Case Summary

This civil case involves Otsuka Pharmaceutical Co., Ltd. and others as plaintiffs against Apotex Inc. and others as defendants. The docket number is 24-cv-01004. The case is currently at a stage where termination of the civil case is being considered, suggesting resolution through settlement, dismissal, or other procedural closure.

Stage

Active litigation

Timeline

4 events

Coverage

4 articles

Sources

1

Key Issues

  • civil litigation
  • pharmaceutical dispute
  • case termination

update What Changed This Week

4 events 4 articles
Advertisement

Case Timeline

4 events
info
Other April 15, 2026

1:25-cv-00311 Sumitomo Pharma Switzerland GmbH et al v. Apotex Inc. et al

In the case involving Sumitomo Pharma Switzerland GmbH and others against Apotex Inc. and others, a formal notice was issued to take a deposition. This means that a witness or party will be questioned under oath before the trial to gather important information. Depositions are crucial for building each side's case and preparing for court proceedings.

info
Other April 15, 2026

1:23-cv-00685 Boehringer Ingelheim Pharmaceuticals Inc. et al v. Apotex Inc. et al

In the case involving Otsuka Pharmaceutical and Apotex, a document related to a separate but connected case between Boehringer Ingelheim Pharmaceuticals and Apotex was filed but has been redacted. This indicates ongoing legal proceedings where sensitive information is being protected. It matters because it shows the complexity and interrelation of patent or pharmaceutical disputes involving Apotex.

info
Other April 15, 2026

1:25-cv-01488 Actelion Pharmaceuticals US, Inc. et al v. Apotex Inc. et al

In the case involving Actelion Pharmaceuticals US, Inc. and Apotex Inc., the parties have proposed a consent judgment, indicating they have reached an agreement to resolve the dispute without further litigation. This development suggests a potential settlement that could avoid a lengthy court battle. It matters because it may expedite resolution and reduce legal costs for both sides.

info
Other April 15, 2026

1:24-cv-01004 Otsuka Pharmaceutical Co., Ltd. et al v. Apotex Inc. et al

The court has officially terminated the civil case between Otsuka Pharmaceutical Co., Ltd. and Apotex Inc. This means the legal dispute has been resolved or dismissed, and no further proceedings will take place in this matter. Terminating the case closes the chapter on the conflict between the parties involved.

Advertisement
show_chart

Coverage Timeline

newspaper

Press Coverage

4 articles